Stay updated on T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial
Sign up to get notified when there's something new on the T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial page.

Latest updates to the T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAdded Revision: v3.4.2 banner on the page. Removed notices about government funding/operating status and the previous v3.4.1 revision.SummaryDifference0.7%

- Check23 days agoChange DetectedAdded a site-wide funding/operating status notice. Updated the history version from v3.4.0 to v3.4.1.SummaryDifference0.7%

- Check30 days agoChange DetectedThe new version adds a glossary display toggle, color-coded change highlights (green for additions, red for deletions) in the study history, and updates the revision label from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check44 days agoChange DetectedA new revision entry v3.3.4 was added to the record history, while v3.3.3 was removed. This update does not alter study data or visible page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page now displays Revision: v3.3.3, and the HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the footer.SummaryDifference0.2%

- Check93 days agoChange DetectedMinor revision label updated from v3.2.0 to v3.3.2 in the record history, a technical metadata change that does not affect study data or page functionality; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial page.